Shimadzu Sponsors New Pharmaceutical Sciences Summer Camp at The University of Toledo
News May 18, 2016
Shimadzu Scientific Instruments announces its sponsorship of the new Shimadzu Pharmaceutical Sciences Summer Camp at The University of Toledo. This two-day camp will take place annually starting June 2016. It will provide qualifying high school students an opportunity to explore the field of pharmaceutical sciences in preparation for a university academic program.
The laboratory- and technology-focused camp gives students a hands-on approach to learn the science behind several pharmaceutical fields, including drug discovery, chemistry, and cosmetic science. Students will explore these topics through laboratory exercises, faculty presentations, career panels, and small group discussions. The camp also provides an opportunity to interact with current UT pharmacy students as well.
“Shimadzu’s generous support of this new multi-year pharmaceutical camp is a true investment in the sciences and the future,” said Dr. Amanda C. Bryant-Friedrich, associate professor of medicinal and biological chemistry. “The camp will provide a new generation of students with a rewarding academic experience and further cement the university’s commitment to the city of Toledo.”
“The University of Toledo has a purpose to enlighten our next generation of students in the pharmaceutical field, and Shimadzu is proud to contribute toward helping reach that goal,” said Terry Adams, vice president of marketing for Shimadzu Scientific Instruments. “This type of hands-on summer camp allows students to have an enriched academic experience to help them understand their potential and realize what they can achieve with hard work and dedication.”
Science, technology, engineering, and mathematics (STEM) disciplines have received considerable attention from federal government agencies and private institutions because they have a beneficial impact on the long-term competitiveness of the U.S., and they play a vital role in the education of future students. Shimadzu’s gift, which covers multiple years and reflects its corporate mission of “contributing to society through science and technology,” will help promote these disciplines to a new generation of scientists.
MIT researchers have developed a cryptographic system that could help neural networks identify promising drug candidates in massive pharmacological datasets, while keeping the data private. Secure computation done at such a massive scale could enable broad pooling of sensitive pharmacological data for predictive drug discovery.